<DOC>
	<DOCNO>NCT01540604</DOCNO>
	<brief_summary>This investigation efficacy safety CRD007 Duchenne Muscular Dystrophy ( DMD ) , Becker Muscular Dystrophy ( BMD ) symptomatic carrier .</brief_summary>
	<brief_title>CRD007 Treatment Duchenne Muscular Dystrophy , Becker Muscular Dystrophy Symptomatic Carriers</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Documented diagnosis dystrophinopathy Severe functional impairment</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>DMD</keyword>
	<keyword>BMD</keyword>
	<keyword>symptomatic carrier</keyword>
</DOC>